GSK Agrees To $6.5M Settlement In Benefiber Labeling Class Suit

Mealey's (June 16, 2021, 8:41 AM EDT) -- NEW YORK — A federal judge in New York on June 8 granted preliminary approval of a $6.5 million settlement in a putative class complaint accusing GSK Consumer Health Inc. of misleading consumers by making false claims on the labels of certain Benefiber products that they are “100% Natural” and “clinically proven to curb cravings.”...